Attenuation of dopamine transporter activity by alpha-synuclein (Q34187960)

31 July 2017

Attenuation of dopamine transporter activity by alpha-synuclein (English)

1 reference

31 July 2017

0 references

1 reference

Christophe Wersinger

1

1 reference

PubMed ID

12672538

31 July 2017

Anita Sidhu

series ordinal

2

1 reference

PubMed ID

12672538

31 July 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

31 July 2017

1 reference

31 July 2017

340

1 reference

31 July 2017

189-192

1 reference

31 July 2017

3

1 reference

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

Degradation of alpha-synuclein by proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

Synucleins in synaptic plasticity and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

Filamentous nerve cell inclusions in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

Physiology and pathophysiology of alpha-synuclein. Cell culture and transgenic animal models based on a Parkinson's disease-associated protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

1 reference

7 January 2021

Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

Alpha-synuclein and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

Recent advances in the genetics and pathogenesis of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

Multiple coupling of human D5 dopamine receptors to guanine nucleotide binding proteins Gs and Gz

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

Age-dependent differential regulation of genes encoding APP and alpha-synuclein in hippocampal synaptic plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900097-1

7 January 2021

10.1016/S0304-3940(03)00097-1

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12672538